Khiron Life Sciences Corp. Announces Formation of Wellness Business Unit, Launch of Its First CBD Cosmeceutical Brand

The first-to-market strategy establishes a cosmeceutical brand in the fast-growing Latin America skin care sector with CBD-based consumer products.


Toronto, Canada – September 28, 2018 – PRESS RELEASE – Khiron Life Sciences Corp., an integrated medical cannabis company with its core operations in Colombia, has announced the creation of Khiron Wellness, and the launch of Kuida, its first CBD-based skincare brand. With this achievement, Kuida becomes the first mass-market CBD-based brand approved by INVIMA, Colombia´s health agency, and available for sale in Colombia.

Khiron’s Wellness business unit is focused on cosmeceutical and nutraceutical products, offering the full benefits of cannabis to consumers across Latin America.

Kuida is the first brand in Colombia that brings the benefits of cannabidiol (CBD) to a comprehensive portfolio of skin and body care products for women. Kuida advances CBD and innovative cosmeceutical ingredients to create its proprietary CBDERM technology, which is proven to be three times more antioxidant than vitamin E, with anti-aging properties, quick absorption and light textures to improve the skin penetration of CBD.

The full Kuida product portfolio can be found at www.Kuidaskincare.com.

Alvaro Torres, co-founder and chief executive officer stated, “In keeping with our stated strategy, the Khiron Wellness business unit and launch of Kuida leverages our global medical cannabis expertise to enter a fast-growing category with immediate revenue generation based on a disruptive, innovative and first-to-market product strategy. We will be launching Kuida across the region, while developing innovative consumer packaged goods into our pipeline. Additionally, Khiron will continue to achieve its milestones related to the ongoing expansion of our cannabis cultivation, development of medical products, and clinics rollout.”

According to Euromonitor, the skincare market in Colombia is over US $5.6 billion in annual sales, with a growth rate of 6 percent in the past five years. Further, the Latin American skincare market is anticipated to reach US $110 billion annually by 2020.

Andres Galofre, co-founder and chief commercial officer stated, “I would like to congratulate our team for their dedication in bringing Kuida, the first INVIMA-approved, CBD-based skincare brand to the market. We understand and promote the benefits of CBD-based cosmeceuticals and the potential for Kuida to have a positive impact on women’s lives, beauty, and well-being across Latin America”.

Kuida will launch and will be a major sponsor at the XVII Feria de Belleza y Salud taking place in Bogota, Colombia from Oct. 3-7, 2018. This event is the largest health and beauty conference in Colombia attracting more than 55,000 attendees to discover new products and latest trends in the industry. Full event details can be found at www.feriabellezaysalud.com

Page 1 of 183
Next Page